SUPERNUS PHARMACEUTICALS, INC. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Supernus Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was 2.82 %, a 37.4% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2022 was 7.12 %, a 5.48% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2021 was 6.75 %, a 63.7% decline from 2020.
  • Supernus Pharmaceuticals, Inc. annual Return On Equity for 2020 was 18.6 %, a 11.4% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 7.12 +0.37 +5.48% Jan 1, 2022 Dec 31, 2022
2021 6.75 -11.8 -63.7% Jan 1, 2021 Dec 31, 2021
2020 18.6 -2.4 -11.4% Jan 1, 2020 Dec 31, 2020
2019 21 -6.47 -23.6% Jan 1, 2019 Dec 31, 2019
2018 27.5 +3.45 +14.4% Jan 1, 2018 Dec 31, 2018
2017 24 -39.7 -62.3% Jan 1, 2017 Dec 31, 2017
2016 63.7 +45.3 +245% Jan 1, 2016 Dec 31, 2016
2015 18.5 +49.9 Jan 1, 2015 Dec 31, 2015
2014 -31.4 +268 +89.5% Jan 1, 2014 Dec 31, 2014
2013 -300 -253 -538% Jan 1, 2013 Dec 31, 2013
2012 -47 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.